Highest Altman Z-Score in Health Care
Health Care sector companies ranked by z-score. Companies ranked by Altman Z-Score, a formula predicting bankruptcy probability. Higher scores indicate lower financial distress risk.
Health Care SectorTop 50 by Z-Score
| # | Company | Z-Score |
|---|---|---|
| 1 | GPCRStructure Therapeutics Inc. | 9.77 |
| 2 | MBXMBX Biosciences, Inc. | 9.64 |
| 3 | JANXJanux Therapeutics, Inc. | 9.17 |
| 4 | UPBUpstream Bio, Inc. | 8.68 |
| 5 | FULCFulcrum Therapeutics, Inc. | 8.44 |
| 6 | CGONCG Oncology, Inc. | 8.02 |
| 7 | TERNTerns Pharmaceuticals, Inc. | 7.86 |
| 8 | ELVNEnliven Therapeutics, Inc. | 7.84 |
| 9 | CGEMCullinan Therapeutics, Inc. | 7.33 |
| 10 | TYRATyra Biosciences, Inc. | 6.83 |
| 11 | EWTXEdgewise Therapeutics, Inc. | 6.82 |
| 12 | VCYTVeracyte, Inc. | 6.19 |
| 13 | JBIOJade Biosciences, Inc. | 6.03 |
| 14 | UTHRUnited Therapeutics | 6.00 |
| 15 | ORICOric Pharmaceuticals, Inc. | 5.96 |
| 16 | AVBPArriVent BioPharma, Inc. | 5.74 |
| 17 | KRYSKrystal Biotech, Inc. | 5.66 |
| 18 | ATXSAstria Therapeutics, Inc. | 5.45 |
| 19 | CRONCronos Group Inc. | 5.38 |
| 20 | IRMDIRADIMED CORP | 5.29 |
| 21 | FLGTFulgent Genetics, Inc. | 5.28 |
| 22 | CPRXCatalyst Pharmaceuticals Partners, Inc. | 4.78 |
| 23 | LENZLENZ Therapeutics, Inc. | 4.71 |
| 24 | CHEChemed Corp. | 4.70 |
| 25 | BLFSBioLife Solutions, Inc. | 4.67 |
| 26 | PTGXProtagonist Therapeutics, Inc. | 4.66 |
| 27 | IDXXIdexx Laboratories | 4.60 |
| 28 | IDYAIDEAYA Biosciences, Inc. | 4.55 |
| 29 | PRAXPraxis Precision Medicines, Inc. | 4.48 |
| 30 | DNTHDianthus Therapeutics, Inc. /DE/ | 4.46 |
| 31 | IRONDisc Medicine, Inc. | 4.41 |
| 32 | ISRGIntuitive Surgical | 4.34 |
| 33 | CORCencora | 4.32 |
| 34 | CAHCardinal Health | 4.27 |
| 35 | DOCSDoximity | 4.19 |
| 36 | IMNMImmunome Inc. | 4.19 |
| 37 | INSPInspire Medical Systems, Inc. | 4.03 |
| 38 | GMEDGlobus Medical | 3.91 |
| 39 | AGIOAGIOS PHARMACEUTICALS, INC. | 3.83 |
| 40 | HUMHumana | 3.80 |
| 41 | BIOABioAge Labs, Inc. | 3.75 |
| 42 | OLMAOlema Pharmaceuticals, Inc. | 3.74 |
| 43 | TCMDTACTILE SYSTEMS TECHNOLOGY INC | 3.70 |
| 44 | MOHMolina Healthcare | 3.65 |
| 45 | VTYXVentyx Biosciences, Inc. | 3.63 |
| 46 | PGNYProgyny | 3.62 |
| 47 | XENEXenon Pharmaceuticals Inc. | 3.51 |
| 48 | WSTWest Pharmaceutical Services | 3.45 |
| 49 | CORTCorcept Therapeutics Incorporated | 3.44 |
| 50 | WATWaters Corporation | 3.41 |
Understanding Altman Z-Score
The Altman Z-Score predicts the likelihood of bankruptcy within two years. It combines five financial ratios: working capital/assets, retained earnings/assets, EBIT/assets, equity/liabilities, and revenue/assets. Scores above 2.9 indicate a "safe zone," 1.23-2.9 is a "grey zone," and below 1.23 suggests "distress zone."
Rankings are based on SEC EDGAR filings. Companies with missing, unreliable, or extreme outlier values are excluded from this ranking.
Related Rankings
Same Sector
For informational purposes only. Not investment advice. Data may be delayed or inaccurate; verify independently. The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results. Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing.